The Cigna Group Reports Fourth Quarter and Full Year 2024 Results, Establishes 2025 Outlook and Increases Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Raymond James Reiterates Strong Buy Rating on CIGNA (CI)
January 30, 2025 8:44 AM ESTRaymond James analyst John Ransom reiterated a Strong Buy rating and $415.00 price target on CIGNA (NYSE: CI)
The analyst comments "Event: This morning, Cigna reported 4Q24 results that significantly missed expectations, with adj. revenue of $65.7B (Street: $63.1B; RJ: $64.9B), adj. EBT of $2.23B (Street $2.78B; RJ: $2.84B), and adj. EPS of $6.64 (Street: $7.82; RJ: $7.78), while MLR came in at 87.9% (Street: 84.7%, RJ: 84.9%). At first glance, the main highlight of the... More
BofA on CIGNA (CI): 'Quarter and outlook disappoint, valuation pressured'
January 30, 2025 8:37 AM ESTBofA Securities analyst Adam Ron reiterated a Buy rating and $420.00 price target on CIGNA (NYSE: CI).
The analyst comments "CI unexpectantly missed 4Q earnings by 13% in the quarter ($1.03), and lowered its view of 2025 by $1.74 (6%). With the new outlook, the company is now... More



